Tirzepatide Telehealth Comparison Compare providers

Is a 12-month tirzepatide plan worth it?

A dated answer with its sources.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

A 12-month plan saves money only if you stay on treatment for the year: as of November 6, 2026, NexLife’s 12-month plan is $115 a month ($1,380 a year) against $129 month to month ($1,548), a $168 saving, and ShedRx’s 12-month rate is $239 against $299. The risk is stopping early because of side effects or cost. Start month to month until you know how you tolerate the dose, and read the refund terms first: NexLife says unshipped months are refunded if treatment stops.

Go deeper

Sources

All answers